Characteristics of published studies evaluating the associations of M. genitalium with pelvic inflammatory disease.

1Cases are those individuals with defined signs or symptoms; controls are individuals without signs or symptoms.2M. genitalium prevalence calculated at enrollment; PID HR calculated from incident infections in prospective study.3M. genitalium prevalence and association with endometritis calculated from infection status and signs at enrollment.4M. genitalium prevalence and association with ectopic pregnancy were evaluated using a serological assay rather than with a NAAT.5Excluded patients co-infected with M. genitalium and CT.6Excluded women with CT and women co-infected with M. genitalium and CT.MG, Mycoplasma genitalium; OR, odds ratio; RR, relative risk; HR, hazard ratio; hpf, high-power microscope field; Ob/Gyn, obstetrics and gynecology; STI, sexually transmitted infection; PID, pelvic inflammatory disease; ER, emergency room; CSW, commercial sex workers; TOP, termination of pregnancy; PHC, public health clinic; PT, self reported partner treatment; A, age; CT, Chlamydia trachomatis status; R, race; IC, intercourse between enrollment and 30-d visit.